"The initiative, announced by the Centers for Medicare & Medicaid Services, is a short-term pilot program known as the Medicare GLP-1 Bridge. It will run from July 1, 2026, through Dec. 31, 2027, and is designed to bridge the gap before a potential longer-term program in 2028."
"To qualify for the GLP-1 medications, individuals must be enrolled in a Medicare Part D plan and meet specific health criteria, including a body mass index of 27 or higher, or a BMI of 35 or higher for automatic qualification."
"About half of GLP-1 users report that these medications are difficult to afford, with a quarter stating they are 'very difficult' to afford, highlighting the financial barriers many face in accessing these treatments."
Starting July 2026, Medicare beneficiaries can access GLP-1 prescriptions for weight loss at a cost of $50 per month. This marks a significant policy shift, as Medicare previously did not cover weight loss treatments. The program, known as the Medicare GLP-1 Bridge, will run until December 2027 and aims to provide coverage for specific GLP-1 medications. Eligibility is based on body weight and health conditions, with a focus on those with a BMI of 27 or higher. Approximately 40% of American adults are clinically obese.
Read at www.npr.org
Unable to calculate read time
Collection
[
|
...
]